Alectinib Approved as an Adjuvant Treatment for Lung Cancer
May 8, 2024, by Sharon Reynolds FDA approved alectinib (Alecensa) for people with non-small cell lung cancer (NSCLC) who have ALK-positive tumors that can be removed with surgery. Credit: © Terese Winslow Some people with non-small cell lung cancer (NSCLC) …